The SHAP-hyaluronan complex in serum from patients with chronic liver diseases caused by hepatitis virus infection

Hepatology Research

Volumn 34, Issue 3, 2006, Pages 178-186

  Shen, Li ^a   Zhuo, Lisheng ^a   Okumura, Akihiko ^a   Ishikawa, Tetsuya ^a   Miyachi, Masahiko ^a   Owa, Yoshihiro ^a   Ishizawa, Tohko ^b   Sugiura, Nobuo ^a,b   Nagata, Yoshihisa ^a   Nonami, Toshiaki ^a   Kakumu, Shinichi ^a   Kimata, Koji ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b Seikagaku Biobusiness Corporation   (Japan)

Author keywords

Chronic hepatitis; Hepatocellular carcinoma; Hyaluronan; Inter trypsin inhibitor; Liver cirrhosis

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; SERUM DERIVED HYALURONAN ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE MARKER; FEMALE; HEPATITIS C; HEPATITIS E; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

EID: 33644634923     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.12.008     Document Type: Article

References (46)

1. C.T. McGary R.H. Raja P.H. Weigel Endocytosis of hyaluronic acid by rat liver endothelial cell. Evidence for receptor recycling Biochem J 257 1989 875-884
2. L. Lebel J.R. Fraser W.S. Kimpton J. Gabrielsson B. Gerdin T.C. Laurent A pharmacokinetic model of intravenously administered hyaluronate in sheep Pharm Res 6 1989 677-682
3. Laurent TC, Fraser JR. The properties and turnover of hyaluronan. In: Functions of protoglycans, Ciba Foundation Symposium 124. Chichester: Wiley; 1986. p. 9-29.
4. T.C. Laurent J.R. Fraser Hyaluronan FASEB J 6 1992 2397-2404
5. T.C. Laurent U.B. Laurent J.R. Fraser The structure and function of hyaluronan: An overview Immunol Cell Biol 74 1996 A1-A7
6. J.R. Fraser T.C. Laurent Hyaluronan W.D. Comper Extracellular matrix vol. 2 1996 Harwood Academic Publishers Amsterdam 141-199
7. S. Eriksson J.R. Fraser T.C. Laurent H. Pertoft B. Smedsrod Endothelial cell are a sit of uptake and degradation of hyaluronic acid in the liver Exp Cell Res 144 1983 223-228
8. N. Pontinha H. Pessegueiro H. Barros Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic virus hepatitis B Scand J Clin Lab Invest 59 5 1999 343-347
9. K. Suzuki R. Endo Y. Takikawa I. Nakadate S. Sato Serum hyaluronate in patients with acute and fulminant hepatitis J Gastroenterol 31 1996 237-241
10. T. Ogata K. Okuda T. Ueno N. Saito S. Aoyagi Serum hyaluronan as a predictor of hepatic regeneration after hepatectomy in humans Eur J Clin Investig 29 1999 780-785
11. T. Satoh T. Ichida Y. Matsuda et. al. Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis J Gastroen Hepatol 15 2000 402-411
12. J.G. McHutchison L.M. Blatt M. de Medina et. al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology J Gastroen Hepatol 15 2000 945-951
13. A. Grzeszczuk T.W. Lapinski A. Panasiuk Levels of hyaluronic acid in chronic virus C hepatitis with relationship to liver steatosis Wiad Lek 55 1-2 2002 35-41
14. L.A. Kopke-Aguiar J.R. Martins C.C. Passerotti C.F. Toledo H.B. Nader D.R. Broges Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schistosomiasis Acta Trop 84 2 2002 117-126
15. B.P. Toole Hyaluronan and its binding proteins, the hyaladherins Curr Opin Cell Biol 2 1990 839-844
16. J.A. Fosang T.E. Hardingham Matrix proteoglycans W.D. Comper Extracellular matrix vol. 2 1996 Harwood Academic Publishers Amsterdam 200-229
17. T.H. Lee H.G. Wisniewski J. Vilcek A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44 J Cell Biol 116 1992 5455-5457
18. T. Shinomura Y. Nishida K. Ito K. Kimata cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationship to versican J Biol Chem 268 1993 14461-14469
19. M. Yoneda S. Suzuki K. Kimata Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85 kDa protein J Biol Chem 265 1990 5247-5257
20. L. Huang M. Yoneda K. Kimata A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter-α-trypsin inhibitor J Biol Chem 268 1993 26725-26730
21. M. Zhao M. Yoneda Y. Ohashi et. al. Evidence for the covalent binding of SHAP, heavy chain of inter-α-trypsin inhibitor, to hyaluronan J Biol Chem 270 1995 26657-26663
22. J.J. Enghild G. Salvesen S.A. Hefta I.B. Thogersen S. Rutherfurd S.V. Pizzo Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-alpha-inhibitor J Biol Chem 266 1991 747-751
23. D. Kida M. Yoneda S. Miyaura et. al. The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis J Rheumatol 26 1999 1230-1238
24. L. Zhuo M. Yoneda M. Zhao et. al. Defect in SHAP-hyaluronan complex causes severe female infertility J Biol Chem 276 2001 7693-7696
25. L. Zhuo L. Shen T. Nonogaki et. al. Biological function of hyaluronan-SHAP covalent complex H.G. Garg C.A. Hales Chemistry and biology of hyaluronan 2004 Elsevier Amsterdam 205-222
26. W. Yingsung L. Zhuo M. Morgelin et. al. Molecular heterogeneity of the SHAP-hyaluronan complex: Isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis J Biol Chem 278 2003 32710-32718
27. G. Fattovich G. Giustina F. Degos et. al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients Gastroenterology 112 1997 463-472
28. M.J. Tong S.Y. Lee S.J. Hwang et. al. Evidence for hepatitis C virus infection in patients with primary hepatocellular carcinoma West J Med 160 1994 133-138
29. K. Murata Y. Ochiai K. Akashio Polydispersity of acidic glycosaminoglycan components in human liver and the changes at different stages in liver cirrhosis Gastroenterology 89 1985 1248-1257
30. A.M. Gressner R. Haarmann Regulation of hyaluronate synthesis in rat liver fat storing cell cultures by Kupffer cells J Hepatol 7 1988 310-318
31. T. Ueno M. Sata K. Tanikawa Cells responsible for extracellular matrix production in the liver I. Okazaki Y. Ninomiya S.L. Friedman K. Tanikawa Extracellular matrix and the liver: Approach to gene therapy 2003 Academic Press Amsterdam 89-103
32. P.R. Gibson J.R. Fraser T.J. Brown et. al. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease Hepatology 15 1992 1054-1059
33. A. Grzeszczuk S. Chlabicz A. Panasiuk Serum hyaluronan as a possible biomarker of liver insufficiency cirrhosis patients Rocz Akad Med Bialymst 47 2002 80-85
34. B.C. Das S. Isaji Y. Kawarada Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice World J Surg 25 2001 266-273
35. T. Frebourg B. Delpech E. Bercoff et. al. Serum hyaluronate in liver diseases: Study by enzymoimmunological assay Hepatology 6 1986 392-395
36. A. Engstrom-Laurent L. Loof A. Nyberg T. Schroder Increased serum hyaluronate in liver disease Hepatology 5 1985 638-642
37. T. Hasegawa T. Sasaki T. Kimura et. al. Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia J Pediatr Surg 35 11 2000 1643-1646
38. H.A. Wyatt A. Dhawan P. Cheeseman G. Mieli-Vergani J.F. Price Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease Arch Dis Child 86 2002 190-193
39. S. Yachida H. Wakabayashi Y. Kokudo et. al. Measurement of serum hyaluronate acid as a predictor of human liver failure after major hepatectomy World J Surg 24 2000 359-364
40. t. Suehiro K. Sugimachi T. Matsumura H. Itasaka A. Taketomi T. Maeda Protein induced by Vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma Cancer 73 1994 2464-2471
41. Y. Koike Y. Shiratori S. Sato et. al. Des-γ-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma Cancer 91 2001 561-569
42. T.E. Jessen L. Odum Role of tumour necrosis factor stimulated gene 6 (TSG-6) in the coupling of inter-a-trypsin inhibitor to hyaluronan in human follicular fluid Reproduction 125 2003 27-31
43. C. Fulop S. Szanto D. Mukhopadhyay et. al. Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice Development 130 2003 2253-2261
44. M. Yoneda M. Zhao L. Zhuo et. al. Role of inter-α-trypsin Inhibitor and hyaluronan-binding proteoglycans in hyaluronan-rich matrix formation G. Abatangelo P.H. Weigel Redefining hyaluronan 2000 Elsevier Amsterdam 21-30
45. M. Zhao M. Yoneda L. Zhuo et. al. J.F. Kennedy G.O. Phillips P.A. Williams V.C. Hascall Hyaluronan: Chemical, biochemical and biological aspects 2002 Woodhead Publishing Ltd. Cambridge 497-500
46. N. Nakashima M. Sobue S. Fukata et. al. Immunohistochemical characterization of extracellular matrix components of yolk sac tumors Virchows Arch B Cell Pathol Incl Mol Pathol 58 4 1990 309-315